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DIFFERENTIATION-LINKED GENE EXPRESSION IN HUMAN
LEUKAEMIA
M. F. GREAVES
From the Membrane Immunology Laboratory, Imperial Cancer Research Fund, London
HUMAN LEUKAEMIC CELLS and established
cell lines have been phenotypically character-
ized by a battery of markers, including con-
ventional hetero-antisera, monoclonal anti-
bodies, lectins and other cell-surface markers
and intracellular enzymes (terminal deoxy-
nucleotidyl transferase, hexosaminidase iso-
enzymes, acid phosphatase). Two leukaemia-
associated membrane antigens have been
isolated and partially characterized. This
analysis reveals subclasses of various leu-
kaemias (e.g. acute lymphoblastic leukaemia,
chronic myeloid leukaemia (CML) in blast
crisis and chronic lymphocytic leukaemia)
which express distinctive composite pheno-
types and have different prognoses. On this
basis these tests now form part of a routine
diagnostic service.
Most ofthe markers identified have a stable
expression in vivo and in vitro. However, in a
minority of cases (, 10%) phenotypic
"shifts" occur in relapse. It is suggested that
the phenotypic profile reflects in qualitative
terms the pattern of normal gene expression
appropriate for the level ofmaturation arrest
ofthe dominant clone. This view is supported
by the identification of normal lymphocyte
and myeloid precursors with essentially the
same phenotypes as their presumed leukaemic
counterparts.
Studies in Phl-chromosome-positive CML
reveal alterations in the level of maturation
arrest of the dominant subelone within the
lymphoid or myeloid lineages; these intra-
clonal changes are taken as strong evidence
for a pluripotential target cell in CML.
Multiple lineage involvement is rare in other
(Phl-negative) leukaemias, but does occur.
Cell lines established from lymphoid and
myeloid leukaemias have been used to
investigate the stringency and r;eversibility
of maturation arrest. Some myeloid cells can
be induced to differentiate further in 'vitro,
but this has not so far been seen with lym-
phoid lines.
Immunological and enzymatic markers
developed in the context of leukaemia diag-
nosis now provide insight into, and access to,
normal and numerically infrequent precursor
cells previously only identified by function
(e.g. colony formation) or general physical
properties (density, size). Developments in
murine experimental haematology suggest
that it will soon be possible to grow such cells
in vitro. The availability ofprobes for normal
precursor cells has several important implica-BRITISH ASSOCIATION FOR CANCER RESEARCH 669
tions including: (1) Analysis of early events
in haemopoietic differentiation, e.g. choice of
cell lineage, T and B lymphocyte clonal
diversification and control ofimmunoglobulin
gene expression; (2) Manipulation of haemo-
poietic cells for marrow transplants in leu-
kaemia and aiding the development of new
selective drugs; (3) Identification of critical
control or coupling points in proliferation and
maturation which may be perturbed in
leukaemia.
BIBLIOGRAPHY
GREAVES, M. F. & JANOSSY, G. (1978) Biochim.
Biophy8. Acta., 516, 193.
GREAVES, M. F. (1979) Immunodiagnosi8 of Cancer.
New York: Marcel Dekker. p. 542
GREAVES, M. F., VERBI, W., REEVES, B. R. & 4
others (1979) Leukaemia Res., 4, 181.
GREAVES, M. F. (1979) E88ay8 in Biochemistry.
London: Academic Press, 15, 78.